FindTrial
Sign In

A study on the medicines prescribed and possible harmful drug combinations in patients with long-term liver disease

Assessment of drug prescription patterns and drug-drug interactions in chronic liver disease patients: a prospective observational study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091932
Enrollment
160
Registered
2025-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere

Interventions

Intervention1: Nil: Nil

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years or older who are diagnosed with chronic liver disease (CLD), with or without comorbidities, and have been prescribed at least two drugs will be included.

Exclusion criteria

Exclusion criteria: Patients who are pregnant or lactating, have incomplete medical records, or are diagnosed with psychiatric, terminal, or cognitive illnesses will be excluded.

Design outcomes

Primary

MeasureTime frame
The study will reveal the most frequently prescribed medications for patient CLD, highlighting any trends or preferences among healthcare providers.Timepoint: 8 months—

Secondary

MeasureTime frame
The study will provide a detailed analysis of potential drug-drug interactions that may occur in patients with Chronic liver Disease, emphasizing the risks and implications for patient safety.Timepoint: 8 months—

Countries

India

Contacts

Public ContactDr Bhargava Rama Karantha

NGSM institute of pharmaceutical sciences

barmanagaraju08@gmail.com9949617946

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026